DENDRITIC AND T CELLS IN ANTI-BACTERIAL Ig RESPONSES
Project Number5R01AI049192-05
Contact PI/Project LeaderSNAPPER, CLIFFORD M
Awardee OrganizationHENRY M. JACKSON FDN FOR THE ADV MIL/MED
Description
Abstract Text
DESCRIPTION (provided by applicant): Infections due to extracellular bacteria
continue to pose a significant global health problem. This is due in large part
to the continual emergence of antibiotic-resistant strains. Hence, there exists
an urgent need for development of protective vaccines. Immunity is mediated by
antibodies to the bacterial polysaccharides (PS) as well as proteins. However,
little is known regarding the parameters that mediate in vivo anti-PS and
anti-protein responses to intact extracellular bacteria, although such
information has relevance to the rational design of immunotherapies for these
agents.
We have established an in vivo model system for investigating the mechanism of
induction of anti-PS and anti-protein Ig isotypes in response to intact
Streptococcus pneumoniae. Specifically, the Ig isotype response to the
phosphorylcholine (PC) determinant, present on the bacterial cell wall C-PS is
studied and compared to the humoral response to a cell wall protein,
pneumococcal surface protein A (PspA). We show that induction of optimal
anti-PC and anti-PspA responses both require CD4+TCR-a/b+ T cells and
B7-dependent costimulation, although memory fails to develop for induction of
PC-specific Ig. Of interest, the mechanisms underlying the T cell-dependence of
these two responses are distinct. We further show that dendritic cells (DCs)
can phagocytose S. pneumoniae upon transfer into naive mice, induce both
anti-PC and anti-PspA Ig responses, and the formation of PspA-specific memory.
The general aims of this application are to elucidate the mechanisms by which
DCs respond to and process an intact extracellular bacterium for induction of
both T cell-dependent PC- and PspA-specific Ig isotypes in vivo, and determine
the mechanisms underlying the distinct forms of T cell help that stimulate
these respective antigen-specific Ig isotype responses. Specifically, we will
utilize a number of in vitro and in vivo model systems to determine 1) the
parameters that regulate DC activation and antigen presentation in response to
R36A, 2) the relative contribution of DC subsets, and 3) the role of DC
cytokines and accessory molecules, including CD40, MHC class 11, and Toll-like
receptors. In this context, 4) the differential requirements for DC stimulation
of T cell help for the anti-PC versus the anti-PspA response will be
determined.
These data will be the first to establish the detailed parameters that mediate
a physiological antigen-specific humoral immune response to an intact
extracellular bacterium, including the delineation of the fundamental
differences between polysaccharide and protein-specific Ig isotype responses.
Public Health Relevance Statement
Data not available.
NIH Spending Category
No NIH Spending Category available.
Project Terms
CD40 moleculeMHC class II antigenStreptococcus pneumoniaeantibacterial antibodyantibody formationantigen presentationbacterial antigensbactericidal immunitycellular immunitycytokinedendritic cellshelper T lymphocytelaboratory mouseprotein biosynthesistissue /cell culture
National Institute of Allergy and Infectious Diseases
CFDA Code
856
DUNS Number
144676566
UEI
UYLKBRENAPG5
Project Start Date
01-April-2001
Project End Date
31-March-2006
Budget Start Date
01-April-2005
Budget End Date
31-March-2006
Project Funding Information for 2005
Total Funding
$259,350
Direct Costs
$175,000
Indirect Costs
$84,350
Year
Funding IC
FY Total Cost by IC
2005
National Institute of Allergy and Infectious Diseases
$259,350
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01AI049192-05
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01AI049192-05
Patents
No Patents information available for 5R01AI049192-05
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01AI049192-05
Clinical Studies
No Clinical Studies information available for 5R01AI049192-05
News and More
Related News Releases
No news release information available for 5R01AI049192-05
History
No Historical information available for 5R01AI049192-05
Similar Projects
No Similar Projects information available for 5R01AI049192-05